22nd Century Group, Inc. (XXII:NASDAQ) closed at $0.198 on October 23, 2026, down 8.34% on the day. The stock trades 100.0% below its 52-week high of $540.00 and 12.6% above its 52-week low of $0.176. Over the past year, it lost 99.2%. 22nd Century Group, Inc. is part of the Health Care sector.
In 251 trading sessions since October 23, 2025, XXII closed higher on 90 days (36%). Its best day was September 23, 2026 (+29.28%) and its worst was October 16, 2026 (-46.57%). The stock moved 10% or more in a single session 43 times. It opened at least 5% above the previous day's high 4 times.
22nd Century Group Inc is a US-based plant biotechnology company. It focuses on developing technology that allows the increase or decrease in the level of nicotine and other nicotinic alkaloids in tobacco plants and levels of cannabinoids in cannabis plants through genetic engineering and plant breeding. The company is engaged in the research and development of potentially less harmful or modified risk tobacco products and novel tobacco plant varieties. Other business activities of the company include manufacture, marketing, sales, and distribution of SPECTRUM and VLN proprietary cigarettes, contract manufacturing of third-party branded tobacco products, research and development of plant varieties of hemp/cannabis, the sale of branded proprietary tobaccos, and among others.
Find more stocks like XXII with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.